Staar Surgical (SR3) Stock Statistics & Valuation Metrics

Staar Surgical has a market cap or net worth of CHF1.18B. The enterprise value is $1.36B.

Staar Surgical has ― shares outstanding. The number of shares has decreased by -2.65% in one year.

Staar Surgical’s return on equity (ROE) is -0.23 and return on invested capital (ROIC) is -11.26%.

The current PE Ratio of Staar Surgical is ―. Staar Surgical’s PEG ratio is -0.05.

In the last 12 months, Staar Surgical had revenue of 239.44M and earned -80.45M in profits. Earnings per share was -1.62.

In the last 12 months, operating cash flow was -50.19M and capital expenditures -4.79M, giving a free cash flow of -54.99M billion.

Staar Surgical pays an annual dividend of ―, resulting in a dividend yield of ―

Staar Surgical upcoming earnings date is Aug 12, 2026, After Close (Confirmed).

Staar Surgical as a current ratio of 4.55, with Debt / Equity ratio of 10.58%

In the past 12 months, Staar Surgical has paid -1.81M in taxes.

Staar Surgical EV to EBITDA ratio is -14.35, with an EV/FCF ratio of -26.34.

Staar Surgical has CHF163.89M in cash and marketable securities with CHF37.29M in debt, giving a net cash position of CHF126.60M billion.

Gross margin is 76.43%, with operating margin of -19.19%, and net profit margin of -33.60%.

The average price target for Staar Surgical is CHF26.43, which is 11.43% higher than the current price. The consensus rating is Moderate Buy